These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12086525)

  • 21. Aspects on estimation of the risk of calcium oxalate crystallization in urine.
    Tiselius HG
    Urol Int; 1991; 47(4):255-9. PubMed ID: 1781112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of laser-probe and photometric determination of the urinary crystallization risk of calcium oxalate.
    Laube N; Hergarten S; Hesse A
    Clin Chem Lab Med; 2002 Jun; 40(6):595-9. PubMed ID: 12211654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the diurnal variation of urinary pH and urinary calcium in urolithiasis: a study in outpatients.
    Murayama T; Sakai N; Yamada T; Takano T
    Int J Urol; 2001 Oct; 8(10):525-31; discussion 532. PubMed ID: 11737477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relevance of the BONN Risk Index for metabolic monitoring of patients with calcium oxalate urolithiasis: a clinical application study of the Urolizer.
    Berg W; Bechler R; Haas C; Laube N
    Urol Res; 2009 Apr; 37(2):55-62. PubMed ID: 19205684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of the risk of calcium oxalate crystallization in urine.
    Tiselius HG
    Urol Res; 1985; 13(6):297-300. PubMed ID: 4095829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Estimation of 24-h excretion of some promotors and inhibitors of crystallization and degree of urine saturation with calcium oxalate in calcium urinary calculi].
    Boruczkowska A
    Pol Arch Med Wewn; 1994 Oct; 92(4):289-98. PubMed ID: 7854956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hippuric acid as a modifier of calcium oxalate crystallisation.
    Laube N; Jansen B; Schneider A; Steffes HJ; Hesse A
    Clin Chem Lab Med; 2001 Mar; 39(3):218-22. PubMed ID: 11350018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and metabolic evaluation of Korean patients with urolithiasis.
    Park KJ; Jeon SS; Han DH; Lee SY
    Scand J Clin Lab Invest; 2011 Oct; 71(6):481-5. PubMed ID: 21714706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary calcium oxalate saturation in 'stone formers' and normal subjects: an application of the EQUIL2 program.
    Robert M; Boularan AM; Colette C; Averous M; Monnier L
    Br J Urol; 1994 Apr; 73(4):358-61. PubMed ID: 8199821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease.
    Tiselius HG
    Clin Chim Acta; 1982 Jul; 122(3):409-18. PubMed ID: 7105424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnesium excretion and calcium oxalate urolithiasis.
    Resnick MI; Munday D; Boyce WH
    Urology; 1982 Oct; 20(4):385-9. PubMed ID: 7147507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystal growth of calcium oxalate in urine of stone-formers and normal controls.
    Achilles W; Dekanić D; Burk M; Schalk C; Tucak A; Karner I
    Urol Res; 1991; 19(3):159-64. PubMed ID: 1887523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circadian variations in the risk of urinary calcium oxalate stone formation.
    Robert M; Roux JO; Bourelly F; Boularan AM; Guiter J; Monnier L
    Br J Urol; 1994 Sep; 74(3):294-7. PubMed ID: 7953257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental determination of multiple thermodynamic and kinetic risk factors for nephrolithiasis in the urine of healthy controls and calcium oxalate stone formers: does a universal discriminator exist?
    Rodgers AL; Webber D; Hibberd B
    Urolithiasis; 2015 Nov; 43(6):479-87. PubMed ID: 26198547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factor analysis and relative supersaturation as tools for identifying calcium oxalate stone-forming dogs.
    Stevenson AE; Robertson WG; Markwell P
    J Small Anim Pract; 2003 Nov; 44(11):491-6. PubMed ID: 14635961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of dietary excesses in animal protein and in sodium on the composition and the crystallization kinetics of calcium oxalate monohydrate in urines of healthy men.
    Kok DJ; Iestra JA; Doorenbos CJ; Papapoulos SE
    J Clin Endocrinol Metab; 1990 Oct; 71(4):861-7. PubMed ID: 2401715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a simple test to estimate urine saturation with calcium oxalate in stone-forming patients.
    Sánchez A; González A; Sarano HD; Reinaldi S
    Int J Urol; 1994 Dec; 1(4):316-8. PubMed ID: 7614393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of calcium oxalate values as indicators of risk for calcium oxalate calcinosis and the degree of urine saturation in patients with calcium urolithiasis and in healthy patients].
    Głuszek J; Boruczkowska A; Kosicka T; Raszeja-Wanic B
    Pol Tyg Lek; 1989 Feb; 44(9):220-2. PubMed ID: 2813183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
    Suzuki K; Mayne K; Doyle IR; Ryall RL
    Scanning Microsc; 1994; 8(3):523-30. PubMed ID: 7747154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.